Letter to the Editor Open Access
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Mar 15, 2022; 14(3): 746-747
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.746
Re: Association between intestinal neoplasms and celiac disease - beyond celiac disease and more
Kenji Okumura, Department of Surgery, Westchester Medical Center / New York Medical College, Valhalla, NY 10595, United States
ORCID number: Kenji Okumura (0000-0002-7751-2624).
Author contributions: Okumura K performed writing the paper.
Conflict-of-interest statement: The authors have declared no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kenji Okumura, MD, Doctor, Department of Surgery, Westchester Medical Center / New York Medical College, 100 Woods Road, Valhalla, NY 10595, United States. kenjiokumura@kyudai.jp
Received: September 26, 2021
Peer-review started: September 26, 2021
First decision: December 4, 2021
Revised: December 17, 2021
Accepted: February 23, 2022
Article in press: February 23, 2022
Published online: March 15, 2022
Processing time: 164 Days and 17.7 Hours

Abstract

The association between celiac disease and enteropathy-associated T cell lymphoma has been known. The pathogenesis of the development of malignant neoplasms remains limited. In addition to celiac disease, we believe that other underlying mechanisms contribute to the developing malignant neoplasms.

Key Words: Celiac disease; Entropathy-associated T cell lymphoma; c-MYC; JAK-STAT

Core Tip: The pathogenesis of enteropathy-associated T cell lymphoma (EATL) remains limited. This letter suggests oncogene mutations were reported and would be pertinent to develop malignant neoplasms in EATL.



TO THE EDITOR

I read with great interest the paper by Wang et al[1] in the issue 13 of World Journal of Gastrointestinal Oncology, a review article regarding the association between intestinal neoplasms and celiac disease. The authors showed that the total risk of small bowel cancer (SBC) and enteropathy-associated T cell lymphoma (EATL) increased in celiac disease (CD) patients. I have agreed with the authors opinions and they mainly mentioned EATL type I, which is associated with CD. The pathogenesis of EATL remains limited, however, as the authors mentioned in the manuscript that CD disrupts cell-level regulation and chronic intestinal inflammation, which leads to the proliferation of intestinal intraepithelial lymphocytes. The presence of chronic inflammation leads to increase the turnover of cell cycle and contribute to the development of neoplasm due to gene mutation in oncogenes or tumor suppressor genes in EATL.

We previously showed that c-myc mutation was seen in EATL type 2[2]. Our findings support that gene mutation is one of the factors developing malignant neoplasm in the absence of celiac disease. JAK/STAT3 signaling pathway was also reported as the main drivers of CD associated lymphomagenesis[3]. JAK/STAT pathway regulates MYC expression[4], which lead to proliferation of malignant cells.

CD is one of the significant gastrointestinal diseases and increases the risk of malignant neoplasms. In addition to CD, we believe that other underlying mechanisms contribute to the developing malignant neoplasms[3]. We believe that these facts would be a helpful to understand CD and EATL and these findings are highly pertinent and provide a context that helps understand those reported by Wang et al[1].

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country/Territory of origin: United States

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B, B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): E

P-Reviewer: Makovicky P, Rostami-Nejad M S-Editor: Wang LL L-Editor: A P-Editor: Wang LL

References
1.  Wang M, Yu M, Kong WJ, Cui M, Gao F. Association between intestinal neoplasms and celiac disease: A review. World J Gastrointest Oncol. 2021;13:1017-1028.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 7]  [Cited by in F6Publishing: 3]  [Article Influence: 1.0]  [Reference Citation Analysis (1)]
2.  Okumura K, Ikebe M, Shimokama T, Takeshita M, Kinjo N, Sugimachi K, Higashi H. An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: A case report. World J Gastroenterol. 2012;18:2434-2437.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
3.  Cording S, Lhermitte L, Malamut G, Berrabah S, Trinquand A, Guegan N, Villarese P, Kaltenbach S, Meresse B, Khater S, Dussiot M, Bras M, Cheminant M, Tesson B, Bole-Feysot C, Bruneau J, Molina TJ, Sibon D, Macintyre E, Hermine O, Cellier C, Asnafi V, Cerf-Bensussan N; CELAC network. Oncogenetic landscape of lymphomagenesis in coeliac disease. Gut. 2021;.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 46]  [Article Influence: 23.0]  [Reference Citation Analysis (0)]
4.  Huang L, Liu D, Wang N, Ling S, Tang Y, Wu J, Hao L, Luo H, Hu X, Sheng L, Zhu L, Wang D, Luo Y, Shang Z, Xiao M, Mao X, Zhou K, Cao L, Dong L, Zheng X, Sui P, He J, Mo S, Yan J, Ao Q, Qiu L, Zhou H, Liu Q, Zhang H, Li J, Jin J, Fu L, Zhao W, Chen J, Du X, Qing G, Liu H, Liu X, Huang G, Ma D, Zhou J, Wang QF. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia. Cell Res. 2018;28:172-186.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 63]  [Article Influence: 9.0]  [Reference Citation Analysis (0)]